Marieke De Bruin to leave CORS
After five years at the head of the Centre, Marieke De Bruin steps down as a Professor at the end of December 2020.
Professor Marieke De Bruin has accepted a new professorship at Utrecht University.
When she arrived at CORS in August 2016, the Centre was taking its first steps to contribute to improving public health and sustainable drug innovation. Under her impulse, the Centre started a number of research projects, including the SAFER project (How best to protect public health: a comparative analysis of regulatory safety warnings on medicines in Australia, Canada the European Union and the United States), and the IMI Gravitate Health.
She also became the supervisor of CORS' first PhD projects, of which one, The development of fixed-dose combinations (FDCs) through improved methodology, was successfully defended in April 2020. Read the thesis.
Prof. De Buin also contributed to major collaborations with institutions across the planet, with the University of Fudan, the University of Sydney and the University of British Columbia, amongst others.
Despite her departure, her ties to CORS are not severed, and she looks forward to taking part in two upcoming PhD defences, one for Louise C. Druedahl, and the other for Mathias Møllebæk. She will also continue her work within the HTx Project (Next Generation Health Technology Assessment) and supervising the PhD project The Impact of Paediatric Regulations on Drug Development in a Transatlantic Perspective.
The whole staff at CORS wishes her very well in her new position in the Netherlands and thanks her for her immense service.
CORS looks forward to announcing a replacement as soon as possible. Associate Professor Christine Hallgreen acts as an Interim Director.